Mary Elizabeth Strek to Enzyme Inhibitors
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Enzyme Inhibitors.
Connection Strength
0.550
-
Therapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.
Score: 0.453
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92.
Score: 0.097